Skip to main content

Table 1 Characteristics of the study population

From: A preoperative nomogram predicting risk of lymph node metastasis for early-stage cervical cancer

Variables

Training set

(N = 5500)

Internal Validation set

(N = 1849)

External Validation set

(N = 455)

Age at diagnosis

  < 45 years

2870 (52.18%)

984 (52.33%)

171 (37.58%)

  >  = 45 years

2670 (47.82%)

865 (46.78%)

284 (62.42%)

Histologic subtype

 Squamous

3483 (63.33%)

1214 (65.66%)

414 (90.99%)

 Adenocarcinoma

1553 (28.24%)

495 (26.77%)

37 (8.13%)

 Others

464 (8.44%)

140 ( 7.57%)

4 (0.88%)

Tumor grade

 I

824 (14.98%)

294 (15.90%)

44 (9.67%)

 II

2449 (44.53%)

800 (43.27%)

158 (34.73%)

 III or IV

2227 (40.49%)

755 (40.83%)

253 (55.60%)

Tumor size

  < 2 cm

1956 (35.56%)

668 (36.13%)

148 (32.53%)

 2 ~ 4(< 4)cm

1572 (28.58%)

528 (28.56%)

205 (45.05%)

 4 ~ 6(< 6)cm

1157 (21.04%)

373 (20.17%)

85 (18.86%)

  > 6 cm

815 (14.82%)

280 (15.14%)

17 (3.74%)

FIGO

 I

3930 (71.45%)

1297 (70.15%)

271 (59.56%)

 II

1570 (28.55%)

552 (29.85%)

184 (40.44%)

 LNM

 No

4470 (81.27%)

1496 (80.91%)

391 (85.93%)

 Yes

1026 (18.65%)

353 (19.09%)

64 (14.07%)

  1. FIGO International Federation of Gynecology and Obstetrics, LNM lymph node metastasis